Literature DB >> 20167535

Role of the adaptive immune system in hypertension.

David G Harrison1, Antony Vinh, Heinrich Lob, Meena S Madhur.   

Abstract

Recent studies have shown that both innate and adaptive immunity contribute to hypertension. Inflammatory cells, including macrophages and T cells accumulate in the vessel wall, particularly in the perivascular fat, and in the kidney of hypertensive animals. Mice lacking lymphocytes are resistant to the development of hypertension, and adoptive transfer of T cells restores hypertensive responses to angiotensin II and DOCA-salt challenge. Immune modulating agents have variable, but often-beneficial effects in ameliorating end-organ damage and blood pressure elevation in experimental hypertension. The mechanisms by which hypertension stimulates an immune response remain unclear, but might involve the formation of neoantigens that activate adaptive immunity. Identification of these neoantigens and understanding how they form might prove useful in the prevention and treatment of this widespread and devastating disease. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167535      PMCID: PMC2843787          DOI: 10.1016/j.coph.2010.01.006

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  35 in total

1.  Immunosuppressive treatment protects against angiotensin II-induced renal damage.

Authors:  Dominik N Muller; Erdenechimeg Shagdarsuren; Joon-Keun Park; Ralf Dechend; Eero Mervaala; Franziska Hampich; Anette Fiebeler; Xinsheng Ju; Piet Finckenberg; Jürgen Theuer; Christiane Viedt; Joerg Kreuzer; Harald Heidecke; Hermann Haller; Martin Zenke; Friedrich C Luft
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Identification of dendritic cells in aortic atherosclerotic lesions in rats with diet-induced hypercholesterolaemia.

Authors:  J Ozmen; Y V Bobryshev; R S A Lord; K W S Ashwell
Journal:  Histol Histopathol       Date:  2002-01       Impact factor: 2.303

3.  Lymphocyte subpopulations in pregnancy complicated by hypertension.

Authors:  Fadia Mahmoud; A Omu; H Abul; S El-Rayes; D Haines
Journal:  J Obstet Gynaecol       Date:  2003-01       Impact factor: 1.246

4.  Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II.

Authors:  Nobukazu Ishizaka; Toru Aizawa; Minoru Ohno; Shin-ichi Usui Si; Ichiro Mori; Shiow-Shih Tang; Julie R Ingelfinger; Satoshi Kimura; Ryozo Nagai
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

Review 5.  Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis.

Authors:  W Palinski; J L Witztum
Journal:  J Intern Med       Date:  2000-03       Impact factor: 8.989

6.  Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system.

Authors:  Heinrich E Lob; Paul J Marvar; Tomasz J Guzik; Shraya Sharma; Louise A McCann; Cornelia Weyand; Frank J Gordon; David G Harrison
Journal:  Hypertension       Date:  2009-12-14       Impact factor: 10.190

Review 7.  Interleukin-17: a mediator of inflammatory responses.

Authors:  J Witowski; K Książek; A Jörres
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

8.  Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats.

Authors:  Mayerly Nava; Yasmir Quiroz; Nosratola Vaziri; Bernardo Rodriguez-Iturbe
Journal:  Am J Physiol Renal Physiol       Date:  2002-11-19

9.  Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

Authors:  Ulf Landmesser; Hua Cai; Sergey Dikalov; Louise McCann; Jinah Hwang; Hanjoong Jo; Steven M Holland; David G Harrison
Journal:  Hypertension       Date:  2002-10       Impact factor: 10.190

10.  Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice.

Authors:  U G Svendsen
Journal:  Acta Pathol Microbiol Scand A       Date:  1976-11
View more
  70 in total

1.  Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.

Authors:  Michael W Brands; Amy K L Banes-Berceli; Edward W Inscho; Hind Al-Azawi; Ashlyn J Allen; Hicham Labazi
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  Vascular receptors as new substrates for matrix metalloproteinases in hypertension and other inflammatory states.

Authors:  Theodore J Kalogeris; Ronald J Korthuis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-16       Impact factor: 4.733

3.  Resurrecting hope for antioxidant treatment of cardiovascular disease: focus on mitochondria.

Authors:  Paul M O'Connor; David D Gutterman
Journal:  Circ Res       Date:  2010-07-09       Impact factor: 17.367

Review 4.  The central nervous system and inflammation in hypertension.

Authors:  Paul J Marvar; Heinrich Lob; Antony Vinh; Faresa Zarreen; David G Harrison
Journal:  Curr Opin Pharmacol       Date:  2010-12-31       Impact factor: 5.547

Review 5.  Interleukin 17 in vascular inflammation.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

6.  Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction.

Authors:  Rob H P Hilgers; Dongqi Xing; Kaizheng Gong; Yiu-Fai Chen; John C Chatham; Suzanne Oparil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-09       Impact factor: 4.733

Review 7.  Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease.

Authors:  Nicholas C Bene; Pilar Alcaide; Henry H Wortis; Iris Z Jaffe
Journal:  Steroids       Date:  2014-04-21       Impact factor: 2.668

Review 8.  Angiotensin II and vascular injury.

Authors:  Augusto C Montezano; Aurelie Nguyen Dinh Cat; Francisco J Rios; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

Review 9.  Dysregulation of T cell subsets in the pathogenesis of hypertension.

Authors:  Songcang Chen; Devendra K Agrawal
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

10.  Toll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive rats.

Authors:  G F Bomfim; C Echem; C B Martins; T J Costa; S M Sartoretto; R A Dos Santos; M A Oliveira; E H Akamine; Z B Fortes; R C Tostes; R C Webb; M H C Carvalho
Journal:  Life Sci       Date:  2014-12-11       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.